1. Home
  2. REGN vs WBD Comparison

REGN vs WBD Comparison

Compare REGN & WBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regeneron Pharmaceuticals Inc.

REGN

Regeneron Pharmaceuticals Inc.

HOLD

Current Price

$755.72

Market Cap

77.5B

Sector

Health Care

ML Signal

HOLD

Logo Warner Bros. Discovery Inc. Series A

WBD

Warner Bros. Discovery Inc. Series A

HOLD

Current Price

$27.30

Market Cap

69.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
REGN
WBD
Founded
1988
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Cable & Other Pay Television Services
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
77.5B
69.9B
IPO Year
1995
2008

Fundamental Metrics

Financial Performance
Metric
REGN
WBD
Price
$755.72
$27.30
Analyst Decision
Buy
Buy
Analyst Count
25
21
Target Price
$821.08
$23.78
AVG Volume (30 Days)
499.1K
23.3M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
0.49%
N/A
EPS Growth
8.19
106.28
EPS
41.48
0.29
Revenue
$5,872,227,000.00
N/A
Revenue This Year
$11.88
$1.17
Revenue Next Year
$10.31
$1.62
P/E Ratio
$18.32
$94.16
Revenue Growth
20.82
N/A
52 Week Low
$476.49
$7.52
52 Week High
$821.11
$29.99

Technical Indicators

Market Signals
Indicator
REGN
WBD
Relative Strength Index (RSI) 50.94 44.46
Support Level $753.49 $27.02
Resistance Level $788.69 $29.42
Average True Range (ATR) 17.54 0.33
MACD 3.04 0.02
Stochastic Oscillator 63.70 48.94

Price Performance

Historical Comparison
REGN
WBD

About REGN Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has early-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).

About WBD Warner Bros. Discovery Inc. Series A

Warner Bros. Discovery operates in three segments: streaming, studios, and linear networks. In 2026, it intends to split its networks from streaming and studios to form two separate companies. The streaming business includes HBO Max, which is rapidly increasing its international footprint in addition to its major presence in the US. Studios include industry leaders in both film and television, which produce movies and television series that are monetized in multiple ways, including theatrical release, sales to third parties, and feeding into Warner's own platforms. global networks consist of basic cable networks like CNN, TNT, TBS, Discovery, HGTV, and The Food Network. The Discovery+ streaming service will remain part of global networks.

Share on Social Networks: